Treatment of glioblastoma multiforme - A new standard

被引：40
|
作者：
Henson, JW
机构：
[1] Massachusetts Gen Hosp, Stephen E & Catherine Pappas Ctr Neurooncol, Neurol Serv, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Div Neuroradiol, Dept Radiol, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
来源：
ARCHIVES OF NEUROLOGY | 2006年 / 63卷 / 03期
关键词：
D O I：
10.1001/archneur.63.3.337
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Glioblastoma multiforme is one of the most lethal and treatment-resistant of human tumors. Among the therapeutic triad of surgery, radiation therapy, and chemotherapy, only radiation therapy has been shown to improve survival.(1) Despite 30 years of intensive efforts to find an effective chemotherapy regimen for glioblastoma multiforme, the median survival of 12 to 15 months has not changed appreciably since the introduction of radiation therapy.
引用
收藏
页码：337 / 341
页数：5
相关论文
共 50 条
  • [1] Nanoformulations for glioblastoma multiforme: a new hope for treatment
    Ortiz, Raul
    Cabeza, Laura
    Perazzoli, Gloria
    Jimenez-Lopez, Julia
    Garcia-Pinel, Beatriz
    Melguizo, Consolacion
    Prados, Jose
    [J]. FUTURE MEDICINAL CHEMISTRY, 2019, 11 (18) : 2461 - 2482
  • [2] New Biomolecular Approaches to the Treatment of Glioblastoma Multiforme
    Bryukhovetskii, I. S.
    Bryukhovetskii, A. S.
    Khotimchenko, Yu. S.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 158 (06) : 794 - 799
  • [3] New biomarkers in diagnostics and treatment of Glioblastoma multiforme
    Polivka, Jiri
    Polivka, Jiri, Jr.
    Topolcan, Ondrej
    Rohan, Vladimir
    Priban, Vladimir
    [J]. TUMOR BIOLOGY, 2012, 33 : 108 - 108
  • [4] Development of a new immunotherapy treatment for glioblastoma multiforme
    Pearson, Joshua R. D.
    Durrant, Lindy G.
    Brentville, Victoria A.
    Pockley, Graham
    McArdle, Stephanie E. B.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [5] New Biomolecular Approaches to the Treatment of Glioblastoma Multiforme
    I. S. Bryukhovetskii
    A. S. Bryukhovetskii
    Yu. S. Khotimchenko
    [J]. Bulletin of Experimental Biology and Medicine, 2015, 158 : 794 - 799
  • [6] Characterising a New Target for the Treatment of Glioblastoma Multiforme
    Taylor, Olivia
    Holien, Jessica
    Gedye, Craig
    Brzozowski, Joshua
    Skelding, Kathryn
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 31 - 32
  • [7] Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
    Burton, Chase
    Das, Arabinda
    McDonald, Daniel
    Vandergrift, William A., III
    Patel, Sunil J.
    Cachia, David
    Bartee, Eric
    [J]. ONCOLYTIC VIROTHERAPY, 2018, 7 : 107 - 116
  • [8] Apatinib treatment for symptomatic pseudoprogression after standard treatment for glioblastoma multiforme: a case report
    Wang, Zheng
    Du, Fangfang
    Sun, Yafang
    Guo, Yang
    Song, Bin
    Wang, Yahong
    Shi, Xiangyu
    Jiang, Wei
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2019, 8 (05) : 752 - 757
  • [9] Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study
    van der Louw, Elles J. T. M.
    Olieman, Joanne F.
    van den Bemt, Patricia M. L. A.
    Bromberg, Jacotine E. C.
    Oomen-de Hoop, Esther
    Neuteboom, Rinze F.
    Catsman-Berrevoets, Coriene E.
    Vincent, Arnaud J. P. E.
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [10] Glioblastoma multiforme: Pathogenesis and treatment
    Alifieris, Constantinos
    Trafalis, Dimitrios T.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2015, 152 : 63 - 82
12345